| Stage | KMX | % of rev | CVNA | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $7.9B | 100.00% | $8.0B | 100.00% | CVNA ×1.02 |
| Gross profit | $799M | 10.15% | $1.5B | 18.92% | CVNA +8.8pp |
| Operating income | $101M | 1.28% | $714M | 8.88% | CVNA +7.6pp |
| Pre-tax income | $223M | 2.83% | $552M | 6.87% | CVNA +4.0pp |
| Net income | $165M | 2.10% | $483M | 6.01% | CVNA +3.9pp |
| Stage | KMX | CVNA | Gap · A − B |
|---|---|---|---|
| Revenue | $7.9B100.00% | $8.0B100.00% | CVNA ×1.02 |
| Gross profit | 10.15%$799M | 18.92%$1.5B | CVNA +8.8pp |
| Operating income | 1.28%$101M | 8.88%$714M | CVNA +7.6pp |
| Pre-tax income | 2.83%$223M | 6.87%$552M | CVNA +4.0pp |
| Net income | 2.10%$165M | 6.01%$483M | CVNA +3.9pp |
No shared counterparties.